183 related articles for article (PubMed ID: 32911213)
1. Prognostic relevance of the posterior resection margin for predicting disease free survival in ampullary adenocarcinoma.
Schneider C; Sodergren MH; Pencavel T; Soggiu F; Bhogal RH; Khan AZ
Surg Oncol; 2020 Dec; 35():211-217. PubMed ID: 32911213
[TBL] [Abstract][Full Text] [Related]
2. Histopathological assessment of prognostic factors in pancreatic resection specimens using a standardised protocol.
Silvanto A; Balamurugan T; Bagwan IN
Pathologica; 2019 Mar; 111(1):24-30. PubMed ID: 31217619
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
[TBL] [Abstract][Full Text] [Related]
4. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
[TBL] [Abstract][Full Text] [Related]
5. R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
Crippa S; Giannone F; Schiavo Lena M; Belfiori G; Partelli S; Tamburrino D; Delpini R; Pagnanelli M; Pecorelli N; Balzano G; Doglioni C; Falconi M
Ann Surg Oncol; 2021 Aug; 28(8):4602-4612. PubMed ID: 33393031
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study.
Moekotte AL; Lof S; Van Roessel S; Fontana M; Dreyer S; Shablak A; Casciani F; Mavroeidis VK; Robinson S; Khalil K; Gradinariu G; Mowbray N; Al-Sarireh B; Fusai GK; Roberts K; White S; Soonawalla Z; Jamieson NB; Salvia R; Besselink MG; Abu Hilal M
Ann Surg; 2020 Dec; 272(6):1086-1093. PubMed ID: 30628913
[TBL] [Abstract][Full Text] [Related]
7. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.
Jin Z; Hartgers ML; Sanhueza CT; Shubert CR; Alberts SR; Truty MJ; Muppa P; Nagorney DM; Smyrk TC; Hassan M; Mahipal A
Eur J Surg Oncol; 2018 May; 44(5):677-683. PubMed ID: 29506768
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM
Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554
[TBL] [Abstract][Full Text] [Related]
10. Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma.
Moekotte AL; van Roessel S; Malleo G; Rajak R; Ecker BL; Fontana M; Han HS; Rabie M; Roberts KJ; Khalil K; White SA; Robinson S; Halimi A; Zarantonello L; Fusai GK; Gradinariu G; Alseidi A; Bonds M; Dreyer S; Jamieson NB; Mowbray N; Al-Sarireh B; Mavroeidis VK; Soonawalla Z; Napoli N; Boggi U; Kent TS; Fisher WE; Tang CN; Bolm L; House MG; Dillhoff ME; Behrman SW; Nakamura M; Ball CG; Berger AC; Christein JD; Zureikat AH; Salem RR; Vollmer CM; Salvia R; Besselink MG; Abu Hilal M; ; Aljarrah R; Barrows C; Cagigas MN; Lai ECH; Wellner U; Aversa J; Dickson PV; Ohtsuka T; Dixon E; Zheng R; Kowalski S; Freedman-Weiss M
Eur J Surg Oncol; 2020 Sep; 46(9):1717-1726. PubMed ID: 32624291
[TBL] [Abstract][Full Text] [Related]
11. Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysis.
Daamen LA; van Goor IWJM; Schouten TJ; Dorland G; van Roessel SR; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):708-716. PubMed ID: 33323293
[TBL] [Abstract][Full Text] [Related]
12. Reporting the margin in pancreaticoduodenectomies: R0 versus R1.
Tampi CS; Nilkanth S; Jagannath P
Indian J Gastroenterol; 2017 Mar; 36(2):81-87. PubMed ID: 28417289
[TBL] [Abstract][Full Text] [Related]
13. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
14. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
[TBL] [Abstract][Full Text] [Related]
15. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
[TBL] [Abstract][Full Text] [Related]
16. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM
HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
[TBL] [Abstract][Full Text] [Related]
18. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
19. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.
Jamieson NB; Foulis AK; Oien KA; Going JJ; Glen P; Dickson EJ; Imrie CW; McKay CJ; Carter R
Ann Surg; 2010 Jun; 251(6):1003-10. PubMed ID: 20485150
[TBL] [Abstract][Full Text] [Related]
20. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma.
Mann K; Gilbert T; Cicconi S; Jackson R; Whelan P; Campbell F; Halloran C; Neoptolemos J; Ghaneh P
Langenbecks Arch Surg; 2019 Jun; 404(4):439-449. PubMed ID: 30972486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
